Project Details
Description
Preserving Beta Cell Function with Tocilizumab in New Onset Type 1 Diabetes
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/13 → 4/30/14 |
Funding
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- NIH NATIONAL INST OF ALLERGY & INFECT DI
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.